AHA 2021: EMPULSE Demonstrates Benefits of Empagliflozin in Patients Hospitalized for Heart Failure
Expert notes that benefits were observed even among patients not already taking guideline-recommended therapies for heart failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.